| # | Title | Journal | Year | Citations |
|---|
| 1 | Renal failure in multiple myeloma: reversibility and impact on the prognosis | European Journal of Haematology | 2000 | 333 |
| 2 | Erythropoietin after a century of research: younger than ever | European Journal of Haematology | 2007 | 329 |
| 3 | Defensins | European Journal of Haematology | 1990 | 282 |
| 4 | Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo | European Journal of Haematology | 2000 | 269 |
| 5 | Human neutrophil granules and secretory vesicles | European Journal of Haematology | 1993 | 269 |
| 6 | Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis | European Journal of Haematology | 1995 | 257 |
| 7 | Isolation and characterization of a tumor necrosis factor binding protein from urine | European Journal of Haematology | 1989 | 234 |
| 8 | Differential expression of microRNAs in hematopoietic cell lineages | European Journal of Haematology | 2008 | 225 |
| 9 | Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression | European Journal of Haematology | 2013 | 222 |
| 10 | Hematological manifestations of copper deficiency: a retrospective review | European Journal of Haematology | 2008 | 219 |
| 11 | Neutropenic enterocolitis in adults: systematic analysis of evidence quality | European Journal of Haematology | 2005 | 214 |
| 12 | Renal function in newly diagnosed multiple myeloma — A demographic study of 1353 patients | European Journal of Haematology | 1994 | 213 |
| 13 | Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care | European Journal of Haematology | 2005 | 210 |
| 14 | Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study | European Journal of Haematology | 2008 | 210 |
| 15 | Optical tweezers for measuring red blood cell elasticity: application to the study of drug response in sickle cell disease | European Journal of Haematology | 2003 | 203 |
| 16 | Abnormality of CD4+CD25+regulatory T cells in idiopathic thrombocytopenic purpura | European Journal of Haematology | 2006 | 199 |
| 17 | Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients | European Journal of Haematology | 2001 | 198 |
| 18 | Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality | European Journal of Haematology | 2007 | 193 |
| 19 | Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union | European Journal of Haematology | 2014 | 190 |
| 20 | Initial versus deferred melphalan‐prednisone therapy for asymptomatic multiple myeloma stage I — A randomized study | European Journal of Haematology | 1993 | 188 |
| 21 | Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland | European Journal of Haematology | 2004 | 183 |
| 22 | Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome | European Journal of Haematology | 2005 | 183 |
| 23 | Health related quality of life in a nationally representative sample of haematological patients | European Journal of Haematology | 2009 | 176 |
| 24 | Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients | European Journal of Haematology | 2006 | 173 |
| 25 | B‐cell receptor signalling and its crosstalk with other pathways in normal and malignant cells | European Journal of Haematology | 2015 | 173 |
| 26 | Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia | European Journal of Haematology | 2004 | 172 |
| 27 | Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption | European Journal of Haematology | 1992 | 172 |
| 28 | Circulating endothelial cells in vascular disorders: new insights into an old concept | European Journal of Haematology | 2000 | 171 |
| 29 | The role of microRNAs in normal and malignant hematopoiesis | European Journal of Haematology | 2010 | 169 |
| 30 | Biology of the hemopoietic microenvironment | European Journal of Haematology | 1992 | 167 |
| 31 | A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia | European Journal of Haematology | 2008 | 163 |
| 32 | Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia | European Journal of Haematology | 2006 | 162 |
| 33 | Antibiotic proteins of polymorphonuclear leukocytes | European Journal of Haematology | 1996 | 151 |
| 34 | IDEC‐C2B8 anti‐CD20 (Rituximab) immunotherapy in patients with low‐grade non‐Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients | European Journal of Haematology | 1999 | 151 |
| 35 | Cardiac status in well-treated patients with thalassemia major | European Journal of Haematology | 2004 | 150 |
| 36 | Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study | European Journal of Haematology | 1996 | 150 |
| 37 | Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: Prospective study of efficacy and leukaemogenicity with therapeutic implications | European Journal of Haematology | 1994 | 148 |
| 38 | High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura | European Journal of Haematology | 2003 | 146 |
| 39 | Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment | European Journal of Haematology | 2006 | 146 |
| 40 | Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea* | European Journal of Haematology | 2009 | 146 |
| 41 | Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high‐dose dexamethasome | European Journal of Haematology | 2007 | 145 |
| 42 | Serum concentrations of DKK‐1 correlate with the extent of bone disease in patients with multiple myeloma | European Journal of Haematology | 2008 | 141 |
| 43 | Blood haemoglobin declines in the elderly: implications for reference intervals fromage 70 to 88 | European Journal of Haematology | 2000 | 139 |
| 44 | Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development | European Journal of Haematology | 1997 | 139 |
| 45 | Adult Langerhans cell histiocytosis | European Journal of Haematology | 2006 | 138 |
| 46 | Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group | European Journal of Haematology | 2007 | 138 |
| 47 | Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia | European Journal of Haematology | 2006 | 137 |
| 48 | The incidence of idiopathic thrombocytopenic purpura among adults: a population‐based study and literature review | European Journal of Haematology | 2009 | 136 |
| 49 | Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma | European Journal of Haematology | 2001 | 136 |
| 50 | Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura | European Journal of Haematology | 2006 | 135 |
